User profiles for Jonathan Valabhji

Jonathan Valabhji

Clinical Chair in Medicine, Imperial College London
Verified email at imperial.ac.uk
Cited by 7409

[HTML][HTML] Obesity as a risk factor for severe COVID-19: summary of the best evidence and implications for health care

N Sattar, J Valabhji - Current Obesity Reports, 2021 - Springer
Purpose of Review To collate the best evidence from several strands—epidemiological,
genetic, comparison with historical data and mechanistic information—and ask whether obesity …

[HTML][HTML] Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study

…, N Sattar, NJ Wareham, B Young, J Valabhji - The lancet Diabetes & …, 2020 - thelancet.com
Background Although diabetes has been associated with COVID-19-related mortality, the
absolute and relative risks for type 1 and type 2 diabetes are unknown. We assessed the …

[HTML][HTML] Changes in health in England, with analysis by English regions and areas of deprivation, 1990–2013: a systematic analysis for the Global Burden of Disease …

…, I Shiue, L Smeeth, A Tedstone, J Valabhji… - The Lancet, 2015 - thelancet.com
Background In the Global Burden of Disease Study 2013 (GBD 2013), knowledge about
health and its determinants has been integrated into a comparable framework to inform health …

Changes in the incidence of lower extremity amputations in individuals with and without diabetes in England between 2004 and 2008

EP Vamos, A Bottle, ME Edmonds, J Valabhji… - Diabetes …, 2010 - Am Diabetes Assoc
OBJECTIVE To describe recent trends in the incidence of nontraumatic amputations among
individuals with and without diabetes and estimate the relative risk of amputations among …

[HTML][HTML] Diabetes and the COVID-19 pandemic

K Khunti, J Valabhji, S Misra - Diabetologia, 2023 - Springer
Almost immediately after the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
virus emerged, it was evident that people with chronic diseases, including diabetes, were …

[HTML][HTML] The impact of the COVID-19 pandemic on diabetes services: planning for a global recovery

…, M McKee, N Tandon, J Valabhji… - The Lancet Diabetes & …, 2022 - thelancet.com
The COVID-19 pandemic has disproportionately affected certain groups, such as older people
(ie, >65 years), minority ethnic populations, and people with specific chronic conditions …

Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study

…, NJ Wareham, N Sattar, B Young, J Valabhji - The lancet Diabetes & …, 2020 - thelancet.com
Background Diabetes has been associated with increased COVID-19-related mortality, but
the association between modifiable risk factors, including hyperglycaemia and obesity, and …

Living risk prediction algorithm (QCOVID) for risk of hospital admission and mortality from coronavirus 19 in adults: national derivation and validation cohort study

…, K Khunti, D Spiegelhalter, A Sheikh, J Valabhji… - bmj, 2020 - bmj.com
Objective To derive and validate a risk prediction algorithm to estimate hospital admission
and mortality outcomes from coronavirus disease 2019 (covid-19) in adults. Design …

Risk prediction of covid-19 related death and hospital admission in adults after covid-19 vaccination: national prospective cohort study

…, RA Lyons, F Kee, A Sheikh, S Rahman, J Valabhji… - bmj, 2021 - bmj.com
Objectives To derive and validate risk prediction algorithms to estimate the risk of covid-19
related mortality and hospital admission in UK adults after one or two doses of covid-19 …

[HTML][HTML] Prescription of glucose-lowering therapies and risk of COVID-19 mortality in people with type 2 diabetes: a nationwide observational study in England

…, A Weaver, E Woch, B Young, J Valabhji - The lancet Diabetes & …, 2021 - thelancet.com
Background In patients with type 2 diabetes, hyperglycaemia is an independent risk factor
for COVID-19-related mortality. Associations between pre-infection prescription for glucose-…